{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-000282","form_type":"8-K","ticker":"BCTX","cik":"0001610820","company_name":"BriaCell Therapeutics Corp.","filed_at":"2025-01-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.184868+00:00","generated_at":"2026-05-28T14:21:35.706850+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"BriaCell announces 1-for-15 share consolidation to maintain Nasdaq listing","bullets":["Consolidation ratio: 1 post-consolidation share for every 15 pre-consolidation shares.","Effective date expected January 24, 2025; trading on TSX and Nasdaq from Jan 29, 2025.","No fractional shares issued; fractions cancelled for no consideration.","Convertible securities exercise prices and share counts proportionally adjusted.","Action needed to comply with Nasdaq Capital Market listing requirements."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-000282","json":"https://secwatch.observer/filing/0001493152-25-000282.json","markdown":"https://secwatch.observer/filing/0001493152-25-000282.md","text":"https://secwatch.observer/filing/0001493152-25-000282.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1610820/000149315225000282/0001493152-25-000282-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1610820/000149315225000282/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T14:21:35.706850+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}